Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP Antivirals for treatment of HCV infections
J05AP07 Daclatasvir
D10105 Daclatasvir dihydrochloride (USAN)
USP drug classification [BR:br08302]
Antivirals
Anti-hepatitis C (HCV) Agents
Daclatasvir
D10105 Daclatasvir dihydrochloride (USAN)
Drug groups [BR:br08330]
Antiviral
DG03198 Anti-HCV agent
DG01999 HCV NS5A inhibitor
DG01669 Daclatasvir
D10105 Daclatasvir dihydrochloride
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01669 Daclatasvir
D10105 Daclatasvir dihydrochloride
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01669 Daclatasvir
D10105 Daclatasvir dihydrochloride
DG02887 UGT1A1 inhibitor
DG01669 Daclatasvir
D10105 Daclatasvir dihydrochloride
Transporter substrate
DG01665 ABCB1 substrate
DG01669 Daclatasvir
D10105 Daclatasvir dihydrochloride
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HCV NS5A/NS5B inhibitor
D10105 Daclatasvir dihydrochloride (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10105
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10105
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10105
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10105
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10105
Drug transporters
D10105
Drug groups [BR:br08330]
Antiviral
DG03198 Anti-HCV agent
DG01999 HCV NS5A inhibitor
DG01669 Daclatasvir
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01669 Daclatasvir
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01669 Daclatasvir
DG02887 UGT1A1 inhibitor
DG01669 Daclatasvir
Transporter substrate
DG01665 ABCB1 substrate
DG01669 Daclatasvir
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HCV NS5A/NS5B inhibitor
DG01669 Daclatasvir